Content matching 'msc'
There are current misconceptions surrounding MSCs, rooted in decades-old science, that are holding the field back.
Webinar Q and A follow-up: ‘Gene-modified mesenchymal stem cells as a potential treatment for Huntington's disease: preparing for a planned Phase I clinical trial’
Cell therapy weekly: Roche acquires MS program and GvHD therapy receives Orphan Drug Designation
Developing a bioanalytical assay for stromal cell therapies: an interview with Laura Deedigan, Orbsen Therapeutics
Latest developments compiled from 1 October until 30 November 2014